Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDeferred TaxesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Amortization (2016 - 2025)

Historic Amortization for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to $83.5 billion.

  • Sanofi's Amortization rose 34.08% to $83.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $83.5 billion, marking a year-over-year increase of 34.08%. This contributed to the annual value of $2.3 billion for FY2025, which is 9728.56% down from last year.
  • According to the latest figures from Q4 2025, Sanofi's Amortization is $83.5 billion, which was up 34.08% from $9.0 billion recorded in Q3 2025.
  • Sanofi's Amortization's 5-year high stood at $83.5 billion during Q4 2025, with a 5-year trough of $2.0 billion in Q4 2021.
  • In the last 5 years, Sanofi's Amortization had a median value of $9.4 billion in 2025 and averaged $22.8 billion.
  • Its Amortization has fluctuated over the past 5 years, first tumbled by 2844.96% in 2024, then skyrocketed by 367653.16% in 2025.
  • Sanofi's Amortization (Quarter) stood at $2.0 billion in 2021, then grew by 10.37% to $2.2 billion in 2022, then surged by 347.05% to $9.8 billion in 2023, then skyrocketed by 751.98% to $83.2 billion in 2024, then rose by 0.34% to $83.5 billion in 2025.
  • Its Amortization was $83.5 billion in Q4 2025, compared to $9.0 billion in Q3 2025 and $23.1 billion in Q2 2025.